Home›People›Mathias Vinther
MV

Mathias Vinther

Director at Navigator Medicines.

Director
Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Mathias Vinther

Mathias Vinther is a director at Navigator Medicines.

Experience

This experience comes from Mathias Vinther's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mathias Vinther in the role, so the role may have started earlier or lasted longer.

Navigator Medicines, Inc. Current
Director, Board of Directors
2024 – Present · San Mateo, CA
Develops antibody treatments for people with inflammatory and autoimmune diseases.
Forbion Current
Partner
2022 – Present
Capstan Therapeutics
Board Observer
2024 – 2025
ReViral
Board Observer
2018 – 2022
Stargazer Pharmaceuticals
Board Observer
2018 – 2022
Novo Holdings
Senior Associate, Novo Ventures
2016 – 2022
VectivBio AG
Board Observer
2019 – 2021
Epsilon-3 Bio
Board Observer
2016 – 2020
Therachon
Board Observer
2018 – 2019
Danish School of Education, Aarhus University
Consultative Support Teacher
2010 – 2011

Key Colleagues at Startups

The people Mathias Vinther works with at each company, as listed on that company's latest Form D.

Navigator Medicines, Inc. · Form D, Sep 25, 2026
KG
Kristie Grebe
Executive officer
ST
Stephen Thomas
Co-Founder and CEO, Sera Medicine, director
SF
Scott Forrest
Chief Financial Officer
TB
Tausif Butt
CEO and President, director
KF
Khurem Farooq
Board Chair
WJ

Sources

  1. SECNavigator Medicines, Inc. Form D, filed Sep 25, 2026